Chronic kidney disease (CKD) is a condition characterized by a gradual loss of renal function over time. To learn more about kidney function, see how your kidneys work. CKD is also known as chronic kidney disease.
This report elaborates the market size, market characteristics, and market growth of the Chronic Kidney Disease (CKD) Drug industry, and breaks down according to the type, application, and consumption area of Chronic Kidney Disease (CKD) Drug. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Chronic Kidney Disease (CKD) Drug in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Chronic Kidney Disease (CKD) Drug market covered in Chapter 13:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Amgen Inc.
Vifor Pharma Ltd
Keryx Biopharmaceuticals
Actavis PLC
Raptor Pharmaceuticals
Rockwell Medical
Shield Therapeutics
OPKO Health
Abbott Laboratories
Takeda Pharmaceuticals
Cara Therapeutics
FibroGen
Regulus Therapeutics
Xenetic Biosciences
AMAG Pharmaceuticals
ZS Pharma
Reata Pharmaceuticals
Pharmacosmos
Akebia Therapeutics
Sanofi

In Chapter 6, on the basis of types, the Chronic Kidney Disease (CKD) Drug market from 2015 to 2025 is primarily split into:
ACE Inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers
Erythropoiesis-stimulating agents (ESAs)
Diuretics
Others

In Chapter 7, on the basis of applications, the Chronic Kidney Disease (CKD) Drug market from 2015 to 2025 covers:
Hospitals
Specialty Clinics

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025